Dr. Olawaiye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Halket St
# Magee-Wo
Pittsburgh, PA 15213Phone+1 412-641-6665Fax+1 412-641-5417
Education & Training
- Massachusetts General HospitalFellowship, Gynecologic Oncology, 2005 - 2008
- University at BuffaloResidency, Obstetrics and Gynecology, 2001 - 2005
- University of IbadanClass of 1991
Certifications & Licensure
- PA State Medical License 2008 - 2024
- MA State Medical License 2005 - 2016
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2008 Dec 01
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2010 Sep 01
- Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2014 Jul 21
Publications & Presentations
PubMed
- Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892).Sarah E Taylor, Sarah Behr, Kristine L Cooper, Haider Mahdi, Denise Fabian
Cancer Chemotherapy and Pharmacology. 2024-12-14 - Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiv...Sarah Bell, Kenneth Smith, Haeyon Kim, Taylor Orellana, Lakshmi Harinath
International Journal of Gynecological Cancer. 2024-12-02 - Association of neighborhood social vulnerability with ovarian cancer survival.Lauren Borho, Esther Elishaev, Riyue Bao, Emily O'Brien, Kaitlyn Dinkins
Gynecologic Oncology. 2024-11-21
Journal Articles
- Survival Advantage Associated with Multimodal Therapy in Women with Node‐Positive (Stage‐IIIC) Uterine Papillary Serous Carcinoma: A National Cancer Database StudyJ F Lin, K Muniz, P Gehrig, R P Edwards, A B Olawaiye, S Beriwal, P Sukumvanich, J L Kelley, BJOG: An International Journal of Obstetrics & Gynaecology
Press Mentions
- Cervical Cancer in Women 65+ Often Deadly: So Why Not Screen?January 19th, 2023
- Cervical Cancer in Women 65+ Often Deadly: So Why Not Screen?January 19th, 2023
- Health Disparities Q&A with Madeleine Courtney-Brooks, MD, MPHApril 11th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: